ASSET | DATE | % RETURN |
---|---|---|
Brera Holdings PLC Class B Ordinary Shares (BREA) | 9/1/2022 - 2/28/2023 | 5,939,900% |
SS Innovations International Inc Common Stock (SSII) | 9/1/2022 - 2/28/2023 | 16,945.45% |
Castellum (CTM) | 9/1/2022 - 2/28/2023 | 7,695.28% |
ENDRA Life Sciences (NDRA) | 9/1/2022 - 2/28/2023 | 1,251.79% |
Cabaletta Bio (CABA) | 9/1/2022 - 2/28/2023 | 820.83% |
Meihua International Medical Technologies (MHUA) | 9/1/2022 - 2/28/2023 | 758.08% |
Cns Pharmaceuticals (CNSP) | 9/1/2022 - 2/28/2023 | 669.23% |
Ucloudlink (UCL) | 9/1/2022 - 2/28/2023 | 632.77% |
Scilex (SCLXW) | 9/1/2022 - 2/28/2023 | 463.64% |
Synergy CHC Corp Common Stock (SNYR) | 9/1/2022 - 2/28/2023 | 390.12% |
Pyxis Tankers (PXSAW) | 9/1/2022 - 2/28/2023 | 376.54% |
Enliven Therapeutics (ELVN) | 9/1/2022 - 2/28/2023 | 364.22% |
Studio City International (MSC) | 9/1/2022 - 2/28/2023 | 302.3% |
Akero Therapeutics (AKRO) | 9/1/2022 - 2/28/2023 | 279.57% |
Madrigal Pharmaceuticals (MDGL) | 9/1/2022 - 2/28/2023 | 278.98% |
ProQR Therapeutics (PRQR) | 9/1/2022 - 2/28/2023 | 278.21% |
United Maritime (USEA) | 9/1/2022 - 2/28/2023 | 277.45% |
Viking Therapeutics (VKTX) | 9/1/2022 - 2/28/2023 | 245.14% |
Immunovant (IMVT) | 9/1/2022 - 2/28/2023 | 244.58% |
Alvotech Warrant (ALVOW) | 9/1/2022 - 2/28/2023 | 225.33% |
Rail Vision Ltd Warrant (RVSNW) | 9/1/2022 - 2/28/2023 | 218.18% |
89bio (ETNB) | 9/1/2022 - 2/28/2023 | 210.25% |
Recon Technology (RCON) | 9/1/2022 - 2/28/2023 | 206.93% |
Sadot (SDOT) | 9/1/2022 - 2/28/2023 | 203.33% |
Ardelyx (ARDX) | 9/1/2022 - 2/28/2023 | 202.05% |